ReviewCancer drug resistance (Alhambra, Calif.)2022

Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo.

Amani Yehya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.